[EN] PYRAZOLE P38 MAP KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA MAP KINASE P38 À BASE DE PYRAZOLE
申请人:RESPIVERT LTD
公开号:WO2011121366A1
公开(公告)日:2011-10-06
There are provided inter alia compounds of formula (I): wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.
其中提供了公式(I)的化合物:其中R1、R2a、R2b、R3、R4、L、X、R5和R6的定义如描述中所述,用于治疗炎症性疾病。